TSLA
Tesla
-- 404.730 NVDA
NVIDIA
-- 134.075 MSTR
MicroStrategy
-- 286.930 FFIE
Faraday Future Intelligent Electric Inc.
-- 2.6850 HOLO
MicroCloud Hologram
-- 5.560 
Update! Top line data expected late 2024
$Sage Therapeutics (SAGE.US)$ Sage Therapeutics Says Phase 2 SURVEYOR Study Strengthens Cognitive Impact Of Huntington's Disease! For Participants With Hd Got Dalzanemdor or Placebo, Dalzanemdor Was Generally Well-Tolerated With No New Safety Signals Observed
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Trytosaveabit OP : Huntington Disease Drug Meets Main Goal in Mid-Stage Study